Dr. Schenk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2014 - 2018
- Clinician Investigator Training Program-, Tumor Immunology, 2014 - 2016
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2011 - 2014
- Mayo Clinic College of MedicineClass of 2011
Certifications & Licensure
- CO State Medical License 2018 - 2025
- MN State Medical License 2012 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Mayo Graduate SchoolPhD
Publications & Presentations
PubMed
- 5 citationsNeoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.Collin M Blakely, Anatoly Urisman, Matthew A Gubens, Claire K Mulvey, Greg M Allen
Journal of Clinical Oncology. 2024-09-10 - 15 citations2020 Innovation-Based Optimism for Lung Cancer Outcomes.Erin L. Schenk, Tejas Patil, Jose M. Pacheco, Paul A. Bunn
The Oncologist. 2021-03-01 - 3 citationsTherapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez
Journal of Clinical Oncology. 2024-04-10
Press Mentions
- How the Immune System Affects Drug Response in Lung Cancer PatientsMay 10th, 2024
- Translational Research Scholar Grant Supports Further Study of Immune Cell Changes During Lung Cancer TreatmentNovember 7th, 2022
- ALK Positive Summit Focuses on Community and SurvivorshipAugust 1st, 2022
- Join now to see all
Committees
- Member, ASCO Expert Panel Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations 2022 - Present
- Member, ASCO Expert Panel Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations 2022 - Present
Professional Memberships
- Member
- Member
- International Association for the Study of Lung CancerMember
External Links
- University of Colorado School of Medicinehttps://som.cuanschutz.edu/Profiles/Faculty/Profile/27915
- UCHelathhttps://www.uchealth.org/provider/erin-schenk-md-phd/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: